Authors:
Stehlin, C
Wurtz, JM
Steinmetz, A
Greiner, E
Schule, R
Moras, D
Renaud, JP
Citation: C. Stehlin et al., X-ray structure of the orphan nuclear receptor ROR beta ligand-binding domain in the active conformation, EMBO J, 20(21), 2001, pp. 5822-5831
Authors:
Egner, U
Heinrich, N
Ruff, M
Gangloff, M
Mueller-Fahrnow, A
Wurtz, JM
Citation: U. Egner et al., Different ligands-different receptor conformations: Modeling of the hER alpha LBD in complex with agonists and antagonists, MED RES REV, 21(6), 2001, pp. 523-539
Authors:
Tocchini-Valentini, G
Rochel, N
Wurtz, JM
Mitschler, A
Moras, D
Citation: G. Tocchini-valentini et al., Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands, P NAS US, 98(10), 2001, pp. 5491-5496
Authors:
Gangloff, M
Ruff, M
Eiler, S
Duclaud, S
Wurtz, JM
Moras, D
Citation: M. Gangloff et al., Crystal structure of a mutant hER alpha ligand-binding domain reveals key structural features for the mechanism of partial agonism, J BIOL CHEM, 276(18), 2001, pp. 15059-15065
Citation: M. Ruff et al., Estrogen receptor transcription and transactivation Structure-function relationship in DNA- and ligand-binding domains of estrogen receptors, BREAST CA R, 2(5), 2000, pp. 353-359
Authors:
Wurtz, JM
Guillot, B
Fagart, J
Moras, D
Tietjen, K
Schindler, M
Citation: Jm. Wurtz et al., A new model for 20-hydroxyecdysone and dibenzoylhydrazine binding: A homology modeling and docking approach, PROTEIN SCI, 9(6), 2000, pp. 1073-1084
Authors:
Hellal-Levy, C
Fagart, J
Souque, A
Wurtz, JM
Moras, D
Rafestin-Oblin, ME
Citation: C. Hellal-levy et al., Crucial role of the H11-H12 loop in stabilizing the active conformation ofthe human mineralocorticoid receptor, MOL ENDOCR, 14(8), 2000, pp. 1210-1221
Authors:
Robin-Jagerschmidt, C
Wurtz, JM
Guillot, B
Gofflo, D
Benhamou, B
Vergezac, A
Ossart, C
Moras, D
Philibert, D
Citation: C. Robin-jagerschmidt et al., Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity, MOL ENDOCR, 14(7), 2000, pp. 1028-1037
Authors:
Auzou, G
Fagart, J
Souque, A
Hellal-Levy, C
Wurtz, JM
Moras, D
Rafestin-Oblin, ME
Citation: G. Auzou et al., A single amino acid mutation of Ala-773 in the mineralocorticoid receptor confers agonist properties to 11 beta-substituted spirolactones, MOLEC PHARM, 58(4), 2000, pp. 684-691
Authors:
Poujol, N
Wurtz, JM
Tahiri, B
Lumbroso, S
Nicolas, JC
Moras, D
Sultan, C
Citation: N. Poujol et al., Specific recognition of androgens by their nuclear receptor - A structure-function study, J BIOL CHEM, 275(31), 2000, pp. 24022-24031
Authors:
Gehin, M
Vivat, V
Wurtz, JM
Losson, R
Chambon, P
Moras, D
Gronemeyer, H
Citation: M. Gehin et al., Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists, CHEM BIOL, 6(8), 1999, pp. 519-529
Authors:
Lavigne, AC
Mengus, G
Gangloff, YG
Wurtz, JM
Davidson, I
Citation: Ac. Lavigne et al., Human TAF(Pi)55 interacts with the vitamin D-3 and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties, MOL CELL B, 19(8), 1999, pp. 5486-5494
Authors:
Greschik, H
Wurtz, JM
Hublitz, P
Kohler, F
Moras, D
Schule, R
Citation: H. Greschik et al., Characterization of the DNA-binding and dimerization properties of the nuclear orphan receptor germ cell nuclear factor, MOL CELL B, 19(1), 1999, pp. 690-703
Authors:
Letz, M
Bringmann, P
Mann, M
Mueller-Fahrnow, A
Reipert, D
Scholz, P
Wurtz, JM
Egner, U
Citation: M. Letz et al., Investigation of the binding interactions of progesterone using muteins ofthe human progesterone receptor ligand binding domain designed on the basis of a three-dimensional protein model, BBA-PROT ST, 1429(2), 1999, pp. 391-400
Authors:
Ylikomi, T
Wurtz, JM
Syvala, H
Passinen, S
Pekki, A
Haverinen, M
Blauer, M
Tuohimaa, P
Gronemeyer, H
Citation: T. Ylikomi et al., Reappraisal of the role of heat shock proteins as regulators of steroid receptor activity, CR R BIOCHE, 33(6), 1998, pp. 437-466